Film actress Madeleine Stowe has signed on as a spokesperson for Sanofi Genzyme, the specialty care global business division of French pharmaceutical company Sanofi.
Stowe will appear in the company's new online webisode series, "Take Action on MS."
The series will provide educational information as well as details on resources for those living with MS. The series will also feature medical professionals such as registered nurses, certified life coaches and exercises specialists as well as real relapsing MS patients.
Stowe has personal knowledge of MS, as her father has the disease. She has spent a great deal of time visiting with MS patients, their caregivers and medical providers.
"Touring the country and having real conversations with people living with relapsing MS and their care partners was more impactful than I could have imagined,” said Stowe. “I had the opportunity to hear directly from people who are battling this disease and gain true insight into the challenges they face on a daily basis, which is why I’m excited to introduce in partnership with Sanofi Genzyme this new video series to continue sharing with the community in a broader way.”
Progress continues to be made in MS treatments. An oral therapy, Aubagio (teriflunomide), was developed by Sanofi as an option for patients with relapsing MS.
"People living with relapsing MS may be uncomfortable talking about certain issues that impact their lives as a result of their disease," said Beverly Layton, a registered nurse specializing in MS, who will appear in "Take Action." "Hearing from others who may be facing similar challenges and knowing you're not alone helps to begin the conversation and empowers people to communicate more openly with family, friends, and healthcare professionals."
The webisodes are available now at www.TakeActionMS.com.
Madeleine Stowe to appear in educational webisode series about MS
Organizations in this Story
Want to get notified whenever we write about Genzyme Corporation ?
Next time we write about Genzyme Corporation, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.Sign-up for Alerts